Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin. - Suppr | 超能文献

Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin.

作者信息

Ellison E C, O'Dorisio T M, Benson G D

出版信息

Am J Surg. 1986 Jun;151(6):668-75. doi: 10.1016/0002-9610(86)90038-3.

DOI:10.1016/0002-9610(86)90038-3

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin.

Am J Surg. 1986 Jun;151(6):668-75. doi: 10.1016/0002-9610(86)90038-3.

2

[Endocrine-active gastrointestinal tumors: are there any new therapeutic possibilities?].[内分泌活性胃肠道肿瘤：是否有新的治疗可能性？]

Dtsch Med Wochenschr. 1986 Jul 11;111(28-29):1120-3. doi: 10.1055/s-2008-1068596.

3

Effects of diphenylhydantoin upon glucose-induced insulin secretion in three patients with insulinoma.苯妥英对三名胰岛素瘤患者葡萄糖诱导的胰岛素分泌的影响。

Diabetes. 1974 Mar;23(3):192-8. doi: 10.2337/diab.23.3.192.

4

Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones.

Ann Intern Med. 1985 Aug;103(2):223-5. doi: 10.7326/0003-4819-103-2-223.

5

Primary endocrine-secreting pancreatic tumors.原发性内分泌分泌性胰腺肿瘤。

Am Fam Physician. 1980 Apr;21(4):94-8.

6

Rebound hypergastrinemia after cessation of a somatostatin analogue (SMS 201-995) in malignant gastrinoma.恶性胃泌素瘤患者停用生长抑素类似物（SMS 201-995）后出现的反弹性高胃泌素血症

Am J Med. 1987 May 29;82(5B):92-5. doi: 10.1016/0002-9343(87)90433-5.

7

Octreotide--a synthetic somatostatin.

Med Lett Drugs Ther. 1989 Jul 14;31(796):66-8.

8

Pseudopancreatic cholera syndrome: effect of a synthetic somatostatin analogue, SMS 201-995.

Am J Med. 1987 May 29;82(5B):84-7. doi: 10.1016/0002-9343(87)90431-1.

9

Vasoactive intestinal peptide producing tumour contains high density of somatostatin receptors.产生血管活性肠肽的肿瘤含有高密度的生长抑素受体。

Lancet. 1987 Mar 28;1(8535):741-2. doi: 10.1016/s0140-6736(87)90375-8.

10

[Current views on endocrine neoplasms of the pancreas (review of the literature)].[关于胰腺内分泌肿瘤的当前观点（文献综述）]

Khirurgiia (Mosk). 1985 Aug(8):135-41.

引用本文的文献

1

Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.奥曲肽。对其药效学和药代动力学特性以及在与肽分泌过多相关病症中的治疗潜力的综述。

Drugs. 1989 Nov;38(5):658-702. doi: 10.2165/00003495-198938050-00002.

2

Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases.长效生长抑素类似物在胃肠道疾病中的治疗潜力。

Gut. 1989 Sep;30(9):1165-72. doi: 10.1136/gut.30.9.1165.

3

Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors.长效生长抑素类似物SMS 201-995在胰岛细胞瘤患者中的应用。

Dig Dis Sci. 1989 Mar;34(3 Suppl):28S-39S. doi: 10.1007/BF01536043.